Previous results revealed that IGF2BP2 bound with HOXD‐AS2 and affected its expression, implying that whether HOXD‐AS2/IGF2BP2 genes' highly expression aggravated glioma progression. Here, IGF2BP2 is linked to central nervous system cancer.